Gritstone bio, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Revenue recognized grant revenue
Collaboration and license revenues
Grant revenues
Contribution revenues
Total revenue recognized grant revenue

Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income
Interest expense
Other expense
Net loss
Other comprehensive loss:
Unrealized loss on marketable securities
Comprehensive loss
Net loss per share, basic
Net loss per share, diluted
Weighted-average number of shares used in computing net loss per share, basic
Weighted-average number of shares used in computing net loss per share, diluted

Comments